Evidence map›Paper›PMID 40385766›Full record

ArticleCureus2025

The Impact of Pathological Margins on Basal Cell Carcinoma Recurrence: Does a Millimetre Matter?

Shahd Nour, Dalia Mohamed, Ouali Braham, Simon Wharton

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shahd NourPlastic and Reconstructive Surgery, Dudley Group NHS Foundation Trust, Birmingham, GBR.
Dalia MohamedPlastic and Reconstructive Surgery, Dudley Group NHS Foundation Trust, Birmingham, GBR.
Ouali BrahamPlastic and Reconstructive Surgery, Dudley Group NHS Foundation Trust, Birmingham, GBR.
Simon WhartonPlastic and Reconstructive Surgery, Dudley Group NHS Foundation Trust, Birmingham, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Basal cell carcinoma (BCC) is the most common skin malignancy worldwide. Existing studies on histopathological margins and recurrence have lacked long-term follow-up and histopathological confirmation, leaving no clear consensus on the optimal margin to minimise recurrence, particularly in the UK population. Objectives This study aimed to evaluate the impact of histopathological margin width on BCC recurrence rates. Specifically, it sought to compare recurrence rates between lesions excised with ≤1 mm and >1 mm margins, assess recurrence patterns over a seven-year follow-up period, and determine whether wider margins had reduced the recurrence risk sufficiently to influence surgical guidelines and multidisciplinary team (MDT) discussions. Methods The Trust histopathology database was analysed to identify all patients with a histological diagnosis of BCC over a two-year period (January 2005 to December 2006). Histopathology reports for these patients were reviewed, and data on patient demographics, lesion site, BCC subtype, and histopathological margins were recorded, along with recurrence details over the subsequent seven years (January 2005 to December 2013). Results Of the 3,551 histopathology reports identified, complete records were available for 965 lesions. Pathological margins of ≤1 mm had been recorded in 269 lesions (narrow margin group), while 696 lesions had margins >1 mm (wide margin group). A total of 13 recurrences (4.8%) occurred in the narrow margin group compared to 14 recurrences (2.0%) in the wide margin group, showing a statistically significant difference (p = 0.017). The anatomical site of the BCC did not significantly impact recurrence, and BCC subtype was not a major determinant, with most subtypes showing no statistically significant association. Conclusion BCC recurrence can be influenced by several factors, including tumour location and size, histological subtype, patient immunosuppression, and follow-up limitations. Our findings confirm that achieving histopathological margins greater than 1 mm during BCC excision reduces the recurrence risk by more than half compared to excisions with ≤1 mm margins. Further research is needed to validate the factors contributing to recurrence, ensuring evidence-based surgical guidelines, MDT discussions, and optimal patient care for BCC management.

Indexed as

basal cell carcinomahistopathological marginsmargin widthrecurrenceskin oncology

Identifiers

PMID40385766
PMCPMC12085063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.